Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels

Atherosclerosis

Volumn 152, Issue 1, 2000, Pages 181-192

  Brites, Fernando D ^a   Bonavita, Carla D ^a   De Geitere, Catherine ^b   Cloës, Marcelo ^b   Delfly, Bernard ^b   Yael, Mario J ^a   Fruchart, Jean Charles ^b   Wikinski, Regina W ^a   Castro, Graciela R ^b  

^a Dept Clin Biochem Sch Pharm B   (Argentina)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Cholesterol efflux; Cholesteryl ester transfer protein (CETP); High density lipoproteins (HDL); Hypertriglyceridemia; Hypoalphalipoproteinemia; Lecithin:cholesterol acyltransferase (LCAT); Reverse cholesterol transport

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYPERTRIGLYCERIDEMIA; HYPOLIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CHOLESTEROL; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS, HDL CHOLESTEROL; MALE; MIDDLE AGE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PROBABILITY; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; SUPPORT, NON-U.S. GOV'T;

EID: 0034283563     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00452-9     Document Type: Article

References (49)

1. The hypertriglyceridemias: risk and management. Am. J. Cardiol. 68:1991;1A-42A.
2. Patsch J.R. Triglyceride-rich lipoproteins and atherosclerosis. Atherosclerosis. 110:1994;S23-S26.
3. Castelli W.P. Epidemiology of triglycerides: a view from Framingham. Am. J. Cardiol. 70:1992;3-9.
4. Gordon D.J., Rifkind B.M. High-density lipoprotein - the clinical implications of recent studies. New Engl. J. Med. 321:1989;1311-1316.
5. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk. 3:1996;213-219.
6. Grundy S.M. A symposium: the role of statins in patients with hypertriglyceridemia. Am J Cardiol 1998;81:1B-73B.
7. Brites F.D., Bonavita C.D., Cloës M., Yael M.J., Fruchart J.C., Castro G.R., et al. VLDL compositional changes and plasma levels of triglycerides and high density lipoprotein. Clin. Chim. Acta. 269:1998;107-124.
8. Fruchart J.C., Ailhaud G. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification and clinical significance. Clin. Chem. 38:1992;793-797.
9. Glomset J.A. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9:1968;155-167.
10. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:1995;211-228.
11. Castro G.R., Fielding C.J. Early incorporation of cell-derived cholesterol into pre-β-migrating high density lipoprotein. Biochemistry. 27:1988;25-29.
12. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271:1996;518-520.
13. Manzato E., Zambon S., Zambon A., Cortella A., Sartore G., et al. Levels and physicochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia. Clin. Chim. Acta. 219:1993;57-65.
14. Hayek T., Azrolan N., Verdery R.B., Walsh A., Chajek-Shaul T., Agellon L.B., et al. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. J. Clin. Invest. 92:1993;1143-1152.
15. Eisemberg S. Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis. Am. Heart J. 113:1997;555-561.
16. Cavallero E., Brites F., Delfly B., Nicolaïew N., Decossin C., De Geitere C., et al. Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles. Arterioscler. Thromb. Vasc. Biol. 15:1995;2130-2135.
17. Tato F., Vega G.L., Grundy S.M. Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase. Arterioscler. Thromb. Vasc. Biol. 17:1997;56-63.
18. NIH Consensus Conference. Triglyceride, high-density lipoprotein and coronary heart disease. J. Am. Med. Assoc. 269:1993;505-510.
19. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). J. Am. Med. Assoc. 269:1993;3015-3023.
20. Okazaki M., Sasamoto K., Muramatsu T., Hosaki S. Analysis of plasma lipoproteins by gel permeation chromatography. Rifai N., Warnick G.R., Dominiczak M.H. Handbook of lipoprotein testing. 1997;531-548 AACC press, Washington.
21. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28:1982;1379-1388.
22. Bartlett G.R. Phosphorus assay column chromatography. J. Biol. Chem. 234:1959;466-468.
23. Assmann G., Jabs H.U., Kohnert U., Nolte W., Schriewer H. LDL (low-density-lipoprotein) cholesterol determination in blood serum following precipitation of LDL with poly(vinil sulphate). Clin. Chim. Acta. 140:1984;77-83.
24. Luc G., Fievet C., Arveiler D., Evans A.E., Bard J.M., Cambien F., Fruchart J.C., et al. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM Study. J. Lipid Res. 37:1996;508-517.
25. De la Llera Moya M., Atger V., Paul J.L., Fournier N., Moatti N., Giral P., et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Arterioscler. Thromb. 14:1994;1056-1065.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
27. Chen C.H., Albers J.J. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity. J. Lipid Res. 23:1982;680-691.
28. Lagrost L., Gandjini H., Athias A., Guyard-Dangremont V., Lallemant C., Gambert P. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler. Thromb. 13:1993;815-825.
29. Mezdour H., Kora I., Parra H.J., Tartar A., Marcel Y.L., Fruchart J.C. Two-site enzyme immunoassay of cholesteryl ester transfer protein with monoclonal and oligoclonal antibodies. Clin. Chem. 40:1994;593-597.
30. Brinton E.A., Eisenberg S., Breslow J.L. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J. Clin. Invest. 87:1991;536-544.
31. Donahue R.P., Abbott R.D., Bloom E., Reed D., Yano K. Central obesity and coronary heart disease in men. Lancet. 8537:1987;821-824.
32. Genest J., Bard J.M., Fruchart J.C., Ordovas J.M., Schaefer E.J. Familial hypoalphalipoproteinemia in premature coronary artery disease. Arterioscler. Thromb. 13:1993;1728-1737.
33. Montali A., Vega G.L., Grundy S.M. Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia. Arterioscler. Thromb. 14:1994;511-517.
34. Von Eckardstein A., Huang Y., Assmann G. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr. Opin. Lipidol. 5:1994;404-416.
35. Brites F.D., Cavallero E., De Geitere C., Nicolaïew N., Jacotot B., Rosseneu M., et al. Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-β particle in type 2 diabetic patients. Clin. Chim. Acta. 279:1999;1-14.
36. Barbaras R., Puchois P., Fruchart J.C., Ailhaud G. Cholesterol efflux from cultured adipose cells is mediated by LpA-I particles but not by LpA-I:A-II particles. Biochem. Biophys. Res. Commun. 142:1987;63-69.
37. Oram J.F., Albers J.J., Cheung M.C., Bierman E.L. The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J. Biol. Chem. 256:1981;8348-8356.
38. Rothblat G.H., Mahlberg F.H., Johnson W.J., Phillips M.C. Apolipoproteins, membrane cholesterol domains and regulation of cholesterol efflux. J. Lipid Res. 33:1992;1091-1097.
39. Syvänne M., Castro G., Dengremont C., De Geitere C., Jauhiainen M., Ehnholm C., et al. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis. 127:1996;245-253.
40. Okazaki M., Hagiwara N., Hara Y. Heterogeneity of human serum high density lipoproteins on high performance liquid chromatography. J. Biochem. 92:1982;517-524.
41. Barrans A., Jaspard B., Barbaras R., Chap H., Perret B., Collet X. Pre-β HDL: structure and metabolism. Biochim. Biophys. Acta. 1300:1996;73-85.
42. Hara H., Yokohama S. Interaction of free apolipoproteins with macrophages. J. Biol. Chem. 266:1991;3080-3086.
43. Bielicki J.K., Johnson W.J., Weinberg R.B., Glick J.M., Rothblat G.H. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J. Lipid Res. 33:1992;1699-1709.
44. Murakami T., Michelagnoli S., Longhi R., Gianfranceschi G., Pazzucconi F., Calabresi L., et al. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler. Thromb. Vasc. Biol. 15:1995;1819-1828.
45. Mann C.J., Yen F.T., Grant A.M., Bihain B.E. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J. Clin. Invest. 88:1991;2059-2066.
46. McPherson R., Agnani G., Lau P., Fruchart J.C., Edgar A.D., Marcel Y.L. Role of Lp A-I and Lp A-I/A-II in cholesteryl ester transfer protein-mediated neutral lipid transfer. Studies in normal subjects and in hypertriglyceridemic patients before and after fenofibrate therapy. Arterioscler. Thromb. Vasc. Biol. 16:1996;1340-1346.
47. Jeppesen J., Ole Hein H., Suadicani P., Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. Arterioscler. Thromb. Vasc. Biol. 17:1997;1114-1120.
48. Asztalos B.F., Lefevre M., Foster T.A., Tulley R., Windhauser M., Wong L., et al. Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations. Arterioscler. Thromb. Vasc. Biol. 17:1997;1885-1893.
49. Austin M.A., King M.C., Vranizan K.M., Krauss R.M. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 82:1990;495-506.